Sarepta Therapeutics

SRPT

Sarepta Therapeutics
$113.79 -$2.85 -2.4%
BATS BZX Real Time Price as of April 22, 2019, 4:00 p.m. View Interactive SRPT Charts

A biopharmaceutical company developing therapeutic products principally based on third-generation NEUGENE antisense technology.

News & Analysis: Sarepta Therapeutics

The Fool has written over 300 articles on Sarepta Therapeutics.

All

Market Moves

Podcasts

Earnings




3 Top Biotech Stocks to Buy in February

Here's why Viking Therapeutics, Cambrex, and Sarepta Therapeutics are all solid biotech plays this month.





3 Biotech Stocks to Watch in 2019

Clinical-trial and regulatory-review decisions make these three drug developers worth keeping tabs on this year.




Interactive Chart